市场调查报告书
商品编码
1395958
中央静脉导管的全球市场 - 市场规模(各市场区隔),占有率,法规,偿付,治疗,预测(~2033年)Central Venous Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
本报告提供全球中央静脉导管市场相关调查分析,提供各市场区隔的市场规模,市场趋势,竞争情形,COVID-19影响等资讯。
市场模式的主要的内容如下列。
目前上市的中央静脉导管和不断变化的竞争格局
世界,地区,国家层级的市场具体考察
透过取得真正的大局(包括医疗保健系统的概述)来促进对市场的了解。此外,市场准入部分可让您透过有关报销政策和监管环境的资讯更深入地了解市场动态。
对象企业
Central Venous Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Drug Delivery Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Central Venous Catheters market for the year 2020 and beyond. Central venous access procedures are performed in patients who require venous access in treatment to deliver medications, nutrients or collect blood samples to perform test. A central venous catheter (CVC) is used in 8-10% of hospital cases with approximately 5 million catheters being inserted in the US every year. The use of CVCs has become the standard practice for the administration of chemotherapy, fluid therapy, medications. They are also used to administer nutrition to patients when there is inadequate gastrointestinal function. These are majorly used in patients with chronic intestinal obstruction, food intolerance, post-operative bowel anastomosis leak, sepsis, polytrauma, and major fractures.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Central Venous Catheters and evolving competitive landscape:
Global, Regional and Country level market specific insights:
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Teleflex Inc, Becton Dickinson and Co, Edwards Lifesciences Corp, Vygon SA, B. Braun Melsungen AG, ICU Medical Inc, Kimal plc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable